Rivaroxaban pharmacokinetics in obese subjects: a systematic review

M Alalawneh, A Awaisu, O Rachid - Clinical Pharmacokinetics, 2022 - Springer
Introduction Venous thromboembolism (VTE) is a leading cause of morbidity and mortality
globally. The direct oral anticoagulants, including rivaroxaban, are relatively novel …

THE EFFECT OF OBESITY ON RIVAROXABAN PHARMACOKINETICS AND PHARMACODYNAMICS

M ALALAWNEH - 2024 - qspace.qu.edu.qa
Venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary
embolism (PE), is a prevalent condition that is associated with high rates of morbidity and …